二甲双胍联合瑞格列奈治疗糖尿病的临床效果观察(2)
第1页 |
参见附件。
[参考文献]
[1] Wild S,Roglic G,Green A,et al.A Global prevalence of diabetes:estimates for the year 2000 and projections for 2030[J].Diabetes Care,2004, 27(5):1047-1053.
[2] Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.Report of the expert committee on the diagnosis and classification of diabetes mellitus[J].Diabetes Care,2003,26(1):5-20.
[3] 美国糖尿病协会(ADA).2010年ADA糖尿病诊疗指南概述[J].糖尿病天地·临床(下旬),2010,4(1):4-12.
[4] Srinivasan A,Joshi P,Raghavan S. Association between waist circumference and serum triacylglcerol status in type 2 diabetes mellitus(T2DM):a study performed on a rural population in puducherry[J].J Clin Diagn Res,2013,7(4):631-634.
[5] Krebs JD,Parry-Strong A,Gamble E,et al. A structured,group-based diabetes self-management education (DSME) programme for people, families and whanau with type 2 diabetes (T2DM)in New Zealand:an observational study[J].Prim Care Diabetes,2013,7(2):151-158.
[6] 田爽.瑞格列奈联合二甲双胍治疗 2 型糖尿病的临床观察[J].中国临床研究,2012,25(2): 136-137.
[7] 陈丽云,武晓泓,蔡娅.传统胰岛素治疗对 2 型糖尿病患者生活质量的影响[J].江苏医药,2007,33(10): 995-997.
[8] 樊永平,王燕,李玉坤.胰岛素皮下注射控制糖尿病应激性高血糖临床观察[J].河北医药,2011,33(1):12-14.
[9] Skouby SO.Diabetes prevention in postmenopausal women:lifestyle,metformin,and sex steroid intervention revisited[J]. Menopause,2013,20(4):365-367.
[10] 研究成果有望降低糖尿病患者罹患肠癌风险[J].北京生物医学工程,2011,30(5):495.
(收稿日期:2013-09-10 本文编辑:魏玉坡)
您现在查看是摘要介绍页,详见PDF附件。